HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early onset ectopia lentis due to a FBN1 mutation with non-penetrance.

Abstract
Isolated ectopia lentis is usually autosomal dominant and commonly due to the mutations of FBN1 gene. We report on a family with ectopia lentis. The propositus is a 6-year-old boy with bilateral superior-temporal ectopia lentis. His echocardiogram was normal and he did not meet the revised Ghent criteria for Marfan syndrome. Molecular genetic testing revealed c.1948 C>T (p.Arg650Cys) in FBN1. The mother has visual acuity of 20/20 with -4.50 right eye and -2.50 left eye. She has no evidence of ectopia lentis. DNA analysis revealed that she has the same FBN1 mutation. Seven other maternal family members also have ectopia lentis. In conclusion, we report on a case of early-onset autosomal dominant isolated ectopia lentis caused by FBN1 mutation that has previously been reported only in Marfan syndrome. The child's mother presumably represents a rare case of nonpenetrance.
AuthorsLi Zhang, Yu-Hung Lai, Jenina E Capasso, Stella Han, Alex V Levin
JournalAmerican journal of medical genetics. Part A (Am J Med Genet A) Vol. 167 Issue 6 Pg. 1365-8 (Jun 2015) ISSN: 1552-4833 [Electronic] United States
PMID25900864 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 Wiley Periodicals, Inc.
Chemical References
  • FBN1 protein, human
  • Fibrillin-1
  • Fibrillins
  • Microfilament Proteins
Topics
  • Adult
  • Age of Onset
  • Aged, 80 and over
  • Child
  • Child, Preschool
  • DNA Mutational Analysis
  • Ectopia Lentis (genetics, pathology)
  • Female
  • Fibrillin-1
  • Fibrillins
  • Gene Expression
  • Genotype
  • Humans
  • Male
  • Microfilament Proteins (genetics)
  • Middle Aged
  • Mutation
  • Pedigree
  • Penetrance
  • Phenotype

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: